miR-4759 suppresses breast cancer through immune checkpoint blockade

Programmed cell death protein 1 (PD-1)/ programmed cell death protein ligand 1 (PD-L1) is the key immune checkpoint governing evasion of advanced cancer from immune surveillance. Immuno-oncology (IO) therapy targeting PD-1/PD-L1 with traditional antibodies is a promising approach to multiple cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, You-Zhe, Liu, Shu-Hsuan, Wu, Wan-Rong, Shen, Yi-Chun, Wang, Yuan-Liang, Liao, Chien-Ching, Lin, Pei-Le, Chang, Han, Liu, Liang-Chih, Cheng, Wei-Chung, Wang, Shao-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718579/
https://www.ncbi.nlm.nih.gov/pubmed/35024096
http://dx.doi.org/10.1016/j.csbj.2021.12.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718579/
https://www.ncbi.nlm.nih.gov/pubmed/35024096
http://dx.doi.org/10.1016/j.csbj.2021.12.020

Ejemplares similares